Back to Wiki

FOXO4-DRI

Anti-Aging

Overview

A senolytic peptide studied for selectively clearing senescent cells (p53/FOXO4 disruption) in longevity research.

Quick Facts

Commonly Available Vial Sizes
2 mg, 10 mg
Typical Research Dose
3,000 – 10,000 mcg (3 – 10 mg)
Suggested BAC Water
2 mL
Category
Anti-Aging

Notes

Senolytic peptide. 10mg vials | Dosing: Every other day (3-6 doses per cycle), 3-6 doses per cycle; 1-3 times/year. Route: Subcutaneous (community); IV (mouse)

Commonly Researched Together

Further Reading

For laboratory and research use only. Not for human consumption or clinical use. Information is provided for reference and does not constitute medical advice.